Advertisement

Topics

BioCardia, Inc. Reports Third Quarter 2017 Financial Results and Business Highlights

12:20 EST 10 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today reported financial results and provided a corporate update for the third quarter ende...

Other Sources for this Article

Investor Contact:
BioCardia, Inc.
David McClung, 650-226-0120
Chief Financial Officer
investors@BioCardia.com

NEXT ARTICLE

More From BioPortfolio on "BioCardia, Inc. Reports Third Quarter 2017 Financial Results and Business Highlights"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...